Are breastfeeding or intend to breastfeed. It is not acknowledged if Evrysdi passes into breast milk and should harm your newborn Risdiplam (Evrysdi®) is the initial oral drug created to treat spinal muscular atrophy (SMA) and it is authorised in several countries around the world. It's authorised for your treatment https://tug-137544210.ezblogz.com/58180387/indicators-on-jx06-you-should-know